Vynleads

Vynleads Equity

The The Equity of Vynleads (VYND) as of Oct 25, 2026 is -352,431.00 USD. In the previous year, The Equity was -227,365.00 USD — a change of 55.01% (lower).

Equity

-352,431.00USD

YoY

55.01%

Last updated:

In 2025, Vynleads's equity was -352,431.00 USD, a 55.01% increase from the -227,365.00 USD equity in the previous year.

The Vynleads Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
50,693.00 USD
Jan 1, 2019
-135,362.00 USD
Jan 1, 2020
-350,285.00 USD
Jan 1, 2021
-491,866.00 USD
Jan 1, 2022
-635,489.00 USD
Jan 1, 2023
-768,926.00 USD
Jan 1, 2024
-227,365.00 USD
Jan 1, 2025
-352,431.00 USD
The Vynleads Equity history
YEAREquityYoY
-352,431.00USD+55.01%
-227,365.00USD-70.43%
-768,926.00USD+21.00%
-635,489.00USD+29.20%
-491,866.00USD+40.42%
-350,285.00USD+158.78%
-135,362.00USD-367.02%
50,693.00USD-90.03%
508,230.00USD-743.17%
-79,020.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vynleads Stock analysis

What does Vynleads do? Vynleads, Inc. generates revenue through the sale of digital guides and nutritional supplements targeting individuals managing type-2 diabetes and pre-diabetes. The company offers The DWD Protocol: Success Blueprint, a digital guide featuring dietary recommendations for a very low calorie eight-week diet, along with modules like The Foundation, The Meal Plan, Diabetes Free Lifestyle, and Taking Control, complemented by recipe books. Additionally, Vynleads sells DWDx3 Advanced Daily Supplement and Premium-Grade Omegax3, which are nutritional supplements designed to support users' health goals. Its primary customers are families seeking natural solutions for diabetes management, who purchase these products to access structured dietary plans and supplement regimens. The company’s products are positioned as educational resources that provide clear, generic blueprints for healthy living, appealing to customers focused on making informed dietary choices. The Lifestyle Blueprint modules and recipe books serve as complementary materials to the core digital guide, enhancing user engagement with the dietary system. Nutritional supplements are sold alongside the digital content, creating a bundled offering that addresses both dietary and nutritional needs for diabetes prevention and control. Vynleads targets customers actively managing type-2 diabetes or pre-diabetes through natural methods, leveraging its digital guide and supplement line to deliver comprehensive solutions. The company’s revenue streams are derived from direct sales of The DWD Protocol: Success Blueprint, its associated modules, recipe books, and the two supplement products, all designed to support users in achieving healthier lifestyles without medical intervention. Vynleads is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Vynleads's Equity

Vynleads's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vynleads's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Vynleads's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Vynleads's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Vynleads’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Vynleads stock

The Equity of Vynleads is -352,431.00 USD in 2025.

The Equity of Vynleads changed from -227,365.00 USD to -352,431.00 USD, representing a 55.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Vynleads since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Vynleads historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Vynleads

All Key Metrics — Vynleads